Search Medical Condition
Please enter condition
Please choose location

Zhuzhou, China Clinical Trials

A listing of Zhuzhou, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy

The total maximum study duration per patient will be 29 weeks that will consist of a 2-week screening period, 26-week treatment period, and a 2-day post-treatment safety follow-up period.

Phase

0.54 miles

Learn More »